Synthesis, DNA binding and antiviral activity of distamycin analogues containing different heterocyclic moieties. 1986

F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
Ricerca & Sviluppo Chimico, Farmitalia Carlo Erba, Milan, Italy.

A series of novel distamycin analogues possessing an additional benzene or heterocyclic ring have been synthesised and tested for selective DNA binding properties and antiviral activity. Inhibition of herpes virus in cell culture appears to be related to AT base pair specificity. Some of the new compounds are also more potent than the parent distamycin against Moloney sarcoma virus.

UI MeSH Term Description Entries
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004214 Distamycins Oligopeptide antibiotics from Streptomyces distallicus. Their binding to DNA inhibits synthesis of nucleic acids.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
September 2002, Bioorganic & medicinal chemistry letters,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
June 1994, Acta chemica Scandinavica (Copenhagen, Denmark : 1989),
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
December 2001, Acta pharmaceutica Hungarica,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
July 1983, Journal of medicinal chemistry,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
May 2002, Bioorganic & medicinal chemistry letters,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
May 2006, Bioorganic & medicinal chemistry,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
December 2003, Bioorganic & medicinal chemistry,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
July 2021, Bioorganic & medicinal chemistry letters,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
October 1994, Biochemical pharmacology,
F Arcamone, and E Lazzari, and M Menozzi, and C Soranzo, and M A Verini
April 2004, Journal of medicinal chemistry,
Copied contents to your clipboard!